HIGHLIGHTS
- who: Jin Liu and colleagues from the Department of Urology, The Third Hospital of Hebei Medical University, Shijiazhuang, China have published the paper: A circadian rhythm-related gene signature for predicting relapse risk and immunotherapeutic effect in prostate adenocarcinoma, in the Journal: (JOURNAL)
- what: This study provided a novel predictor of relapse risk and immunotherapeutic effects of patients with PRAD, which would help to develop precision medicine. This research has several practical meanings for clinical management of PRAD patients. This study has several limitations that need attention.
- how: The results showed that CR . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.